Sanofi Receives CE Mark Approval for Reusable Insulin Pen

by Kathy Jones on  October 12, 2013 at 8:37 PM Medical Gadgets
RSS Email Print This Page Comment bookmark
Font : A-A+

French drugmaker Sanofi announced that it has received the CE Mark Approval for its reusable insulin pen called JuniorSTAR.
 Sanofi Receives CE Mark Approval for Reusable Insulin Pen
Sanofi Receives CE Mark Approval for Reusable Insulin Pen

The pen comes with half unit dosing increment and has been developed for children and teenagers between six and 18 years of age who are suffering from Type-1 diabetes. The pen can work with Lantus (insulin glargine), Apidra (insulin glulisine) or Insuman (recombinant human insulin) and can deliver between 1 to 30 units per injection and has a single-step dial back.

"Everyone deserves high-quality care while learning to manage their diabetes, for the best chances in life. With JuniorSTAR, we aim to meet the needs of type 1 patients worldwide, specifically the younger ones, who need an easy-to-use pen device." This is a welcome addition to our comprehensive portfolio of established insulins, which leads the way in personalized diabetes care', the Senior Vice President, Global Diabetes, Sanofi, Pierre Chancel said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetes - Essentials Phimosis/Circumcision Hypospadias Urology Paediatric Emergencies Gestational diabetes Type 2 Diabetes Diabetes - Foot Care Diabesity Diabetes in Pets Diabetes Facts and Figures 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive